ATIA
BMY icon

American Trust Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

American Trust Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$224K Buy
+3,693
New +$215K 0.12% 74
2025
Q3 		– Sell
-5,109
Closed -$236K – 86
2025
Q2 		$236K Sell
5,109
-13,689
-73% -$672K 0.12% 78
2025
Q1 		$1.15M Buy
18,798
+602
+3% +$35.1K 0.48% 43
2024
Q4 		$1.03M Sell
18,196
-95
-0.5% -$5.31K 0.42% 43
2024
Q3 		$946K Buy
18,291
+5,175
+39% +$243K 0.39% 45
2024
Q2 		$545K Buy
13,116
+654
+5% +$29.3K 0.26% 50
2024
Q1 		$676K Buy
12,462
+701
+6% +$35.7K 0.32% 46
2023
Q4 		$603K Buy
11,761
+804
+7% +$42.2K 0.31% 47
2023
Q3 		$636K Sell
10,957
-109
-1% -$6.68K 0.35% 47
2023
Q2 		$708K Buy
11,066
+425
+4% +$28.5K 0.4% 46
2023
Q1 		$738K Sell
10,641
-19
-0.2% -$1.34K 0.44% 44
2022
Q4 		$767K Buy
10,660
+120
+1% +$9.05K 0.49% 43
2022
Q3 		$749K Buy
10,540
+82
+0.8% +$5.95K 0.48% 46
2022
Q2 		$805K Buy
10,458
+40
+0.4% +$3.05K 0.5% 46
2022
Q1 		$761K Buy
10,418
+160
+2% +$10.7K 0.39% 52
2021
Q4 		$640K Buy
10,258
+1,755
+21% +$103K 0.32% 52
2021
Q3 		$503K Buy
8,503
+210
+3% +$13.8K 0.28% 53
2021
Q2 		$554K Buy
8,293
+910
+12% +$59.3K 0.3% 51
2021
Q1 		$466K Buy
7,383
+2,995
+68% +$186K 0.27% 53
2020
Q4 		$272K Buy
+4,388
New +$270K 0.17% 65
2017
Q1 		– Sell
-3,900
Closed -$228K – 76
2016
Q4 		$228K Hold
3,900
– – 0.22% 60
2016
Q3 		$210K Buy
3,900
+820
+27% +$52.7K 0.21% 61
2016
Q2 		$227K Buy
+3,080
New +$218K 0.23% 61
2016
Q1 		– Sell
-2,950
Closed -$203K – 70
2015
Q4 		$203K Buy
+2,950
New +$195K 0.23% 66
2015
Q3 		– Sell
-3,300
Closed -$220K – 70
2015
Q2 		$220K Hold
3,300
– – 0.22% 66
2015
Q1 		$213K Sell
3,300
-315
-9% -$19.7K 0.21% 63
2014
Q4 		$213K Buy
+3,615
New +$204K 0.23% 61

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Trust Investment Advisors's BMY Position: Q1 2026 in Review

American Trust Investment Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 3,693 shares worth $224K. The stake represents 0.12% of the portfolio and ranks #74 among its holdings. This is a return to the name: American Trust Investment Advisors previously reported a position in BMY as recently as Q2 2025.

American Trust Investment Advisors first reported a position in BMY in Q4 2014 and has held it in 27 quarters since. The position peaked at $1.15M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • American Trust Investment Advisors held 3,693 shares of Bristol-Myers Squibb worth $224K as of Q1 2026.
  • Bristol-Myers Squibb was a new American Trust Investment Advisors position in Q1 2026.
  • Bristol-Myers Squibb made up 0.12% of American Trust Investment Advisors's portfolio in Q1 2026, its #74 holding.
  • American Trust Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 27 quarters since.
  • American Trust Investment Advisors's Bristol-Myers Squibb position peaked at $1.15M in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on American Trust Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.